Can GLP-1 Medications Cause Vision Loss? The New FDA Warning Explained

From Peptides Explained · 10:28

Show by John Garrett

True-Sciences.com use code PEP30 for 30% off your first order through Nov 22, 2026. After that it goes back to 20% off with PEP20 **Excuse the hoarseness in my voice...I am fighting off a cold that is going around my family...so far, I've only gotten hoarse. The FDA is requiring new warnings for GLP-1 medications after reviewing a possible association with non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can cause sudden and sometimes permanent vision loss. John Garrett explains what NAION is, how to interpret the FDA's trial data, what European regulators concluded about semaglutide, and why the evidence should be taken seriously without exaggerating individual risk. Sudden vision loss warrants emergency evaluation. Sources and further reading: FDA https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential ; EMA https://www.ema.europa.eu/en/news/prac-concludes-eye-condition-naion-very-rare-side-effect-semaglutide-medicines-ozempic-rybelsus-wegovy

More episodes of Peptides Explained

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.